Tag: AbbVie Inc
Drugmakers agree to Medicare drug price negotiations: What’s next
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020.George Frey | ReutersAl [...]
Judge denies request to block
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020.George Frey | ReutersA [...]
Medicare drug price negotiations may have muted impact on drugmakers
In this photo illustration, Eliquis is made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois.Scott Olso [...]
10 drugs to face Medicare price negotiations: See the list
The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medi [...]
CVS Health, Sandoz partner on discount Humira biosimilar
Rafael Henrique | Lightrocket | Getty ImagesCVS Health is partnering with drugmaker Sandoz to produce a near identical version of the blockbuster arth [...]
Hepatitis C cure isn’t reaching patients due to cost, CDC says
Hepatitis C virusBSIP | UIG | Getty ImagesThe overwhelming majority of people in the U.S. who have tested positive for hepatitis C have not been cured [...]
Drugmakers aim to fight Medicare negotiations at SCOTUS
Chief Executive Officers of pharmaceutical companies testify before the Senate Finance Committee on "Drug Pricing in America: A Prescription for Chang [...]
GOP law cut Big Pharma tax rates by 40%, Senate report says
(L-R) Richard A. Gonzalez, chairman and CEO of AbbVie Inc., Pascal Soriot, executive director and CEO of AstraZeneca, Giovanni Caforio, chairman of th [...]
We’re exiting a drug stock for a nice gain and putting some of that money to work elsewhere
Traders work on the floor of the New York Stock Exchange (NYSE) on October 27, 2022 in New York City. Stocks continued their upward gains Thursday wit [...]
New stocks, 2 trades, earnings recap
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Friday's key moments. L [...]
Multiple revenue misses in one of our winners convinced us to take profits and get out
We never like to sell on a down day. But after an iffy quarter, we decided to exit.
www.cnbc.com [...]
Still oversold, picking at chip stocks, Club names in the news
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Friday's key moments. M [...]
Passage of Inflation Reduction Act gives Medicare historic new powers
A pharmacist collects medications for prescriptions at a pharmacy.Simon Dawson | Bloomberg | Getty ImagesMedicare is poised to renegotiate the prices [...]
AbbVie's mixed quarter doesn't warrant a 5% stock drop. Here's why
It wasn't a clean quarter from AbbVie but Friday's selloff is a bit confusing.
www.cnbc.com [...]
Tuesday's market bounce allows us to raise some cash to buy in the next downturn
We're raising cash about equal to what we put to work last Friday in three trades when the market was much lower.
www.cnbc.com [...]